Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
9.00
+0.10 (1.18%)
At close: May 16, 2025, 4:00 PM
9.01
+0.02 (0.17%)
After-hours: May 16, 2025, 5:10 PM EDT
Avadel Pharmaceuticals Market Cap
Avadel Pharmaceuticals has a market cap or net worth of $871.62 million as of May 16, 2025. Its market cap has decreased by -47.01% in one year.
Market Cap
871.62M
Enterprise Value
845.52M
1-Year Change
-47.01%
Ranking
Category
Stock Price
$9.00
Market Cap Chart
Since December 31, 2002, Avadel Pharmaceuticals's market cap has increased from $70.50M to $871.62M, an increase of 1,136.34%. That is a compound annual growth rate of 11.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2025 | 860.00M | -15.09% |
| Dec 31, 2024 | 1.01B | -20.13% |
| Dec 29, 2023 | 1.27B | 186.71% |
| Dec 30, 2022 | 442.30M | -6.63% |
| Dec 31, 2021 | 473.70M | 21.68% |
| Dec 31, 2020 | 389.30M | 37.71% |
| Dec 31, 2019 | 282.70M | 196.02% |
| Dec 31, 2018 | 95.50M | -70.71% |
| Dec 29, 2017 | 326.10M | -23.90% |
| Dec 30, 2016 | 428.50M | -12.68% |
| Dec 31, 2015 | 490.70M | 11.85% |
| Dec 31, 2014 | 438.70M | 118.37% |
| Dec 31, 2013 | 200.90M | 165.74% |
| Dec 31, 2012 | 75.60M | -41.12% |
| Dec 30, 2011 | 128.40M | -22.88% |
| Dec 31, 2010 | 166.50M | -7.04% |
| Dec 31, 2009 | 179.10M | 89.93% |
| Dec 31, 2008 | 94.30M | -60.61% |
| Dec 31, 2007 | 239.40M | -66.28% |
| Dec 29, 2006 | 710.00M | 72.88% |
| Dec 30, 2005 | 410.70M | -1.49% |
| Dec 31, 2004 | 416.90M | -3.92% |
| Dec 31, 2003 | 433.90M | 515.46% |
| Dec 31, 2002 | 70.50M | - |
View and export this data all the way back to 2002.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |